Funding for this research was provided by:
Health Technology Assessment Programme (10/62/03)
Received: 31 March 2018
Accepted: 7 August 2018
First Online: 4 September 2018
Ethics approval and consent to participate
: The MOVE IT trial and this response bias study was granted ethics approval by the Dulwich ethics committee (12/LO/0917). Approval was granted by the Dulwich ethics committee to extract anonymised data for all patients invited to participate, unless an informed dissent code was present on their personal medical records, and the requirement to obtain consent from responders and non-responders to the original study for the use of their anonymised data was waived.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.